NSCP Conference Panel — Examining Ethics: Enforcement Actions and Lessons Learned
30 October 2024
Foley partner Jim Lundy will moderate a panel at the National Society of Compliance Professionals National Conference focusing on lessons learned from enforcement actions ripped from the headlines. This session will focus on the reason for the failure of ethics programs, specific attention to up-to-date regulatory scrutiny and expectations.
Attendees will have the opportunity to:
- Analyze what went wrong in high profile cases of violations of ethical codes of conduct, examining the specific concerns of the regulators.
- Discuss the role of the Compliance Department when navigating problematic employee behavior resulting in the most challenging ethical scenarios.
- Learn how to mitigate common ethical pitfalls.
- Review the current Enforcement Division approach to CCO Liability
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.